406 related articles for article (PubMed ID: 30379948)
1. Anticholinergic burden in adult and elderly people with intellectual disabilities: Results from an Italian multicenter cross-sectional study.
De Vreese LP; Mantesso U; De Bastiani E; Marangoni A; Weger E; Gomiero T
PLoS One; 2018; 13(10):e0205897. PubMed ID: 30379948
[TBL] [Abstract][Full Text] [Related]
2. Association of anticholinergic burden with adverse effects in older people with intellectual disabilities: an observational cross-sectional study.
O'Dwyer M; Maidment ID; Bennett K; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
Br J Psychiatry; 2016 Dec; 209(6):504-510. PubMed ID: 27660331
[TBL] [Abstract][Full Text] [Related]
3. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
[TBL] [Abstract][Full Text] [Related]
4. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
[TBL] [Abstract][Full Text] [Related]
5. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
[TBL] [Abstract][Full Text] [Related]
6. Anticholinergic Medication Burden and 5-Year Risk of Hospitalization and Death in Nursing Home Elderly Residents With Coronary Artery Disease.
Vetrano DL; La Carpia D; Grande G; Casucci P; Bacelli T; Bernabei R; Onder G;
J Am Med Dir Assoc; 2016 Nov; 17(11):1056-1059. PubMed ID: 27590402
[TBL] [Abstract][Full Text] [Related]
7. Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.
Campbell NL; Perkins AJ; Bradt P; Perk S; Wielage RC; Boustani MA; Ng DB
Pharmacotherapy; 2016 Nov; 36(11):1123-1131. PubMed ID: 27711982
[TBL] [Abstract][Full Text] [Related]
8. Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home.
Landi F; Dell'Aquila G; Collamati A; Martone AM; Zuliani G; Gasperini B; Eusebi P; Lattanzio F; Cherubini A
J Am Med Dir Assoc; 2014; 15(11):825-9. PubMed ID: 25282629
[TBL] [Abstract][Full Text] [Related]
9. Atropinic (anticholinergic) burden in antipsychotic-treated patients.
Montastruc F; Benevent J; Touafchia A; Chebane L; Araujo M; Guitton-Bondon E; Durrieu G; Arbus C; Schmitt L; Begaud B; Montastruc JL
Fundam Clin Pharmacol; 2018 Feb; 32(1):114-119. PubMed ID: 28887902
[TBL] [Abstract][Full Text] [Related]
10. Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.
Green AR; Reifler LM; Boyd CM; Weffald LA; Bayliss EA
Drugs Aging; 2018 Mar; 35(3):223-232. PubMed ID: 29404965
[TBL] [Abstract][Full Text] [Related]
11. Medication burden and frailty in older adults with intellectual disability: An observational cross-sectional study.
O'Connell J; Henman MC; McMahon N; Burke É; McCallion P; McCarron M; O'Dwyer M
Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):482-492. PubMed ID: 32134549
[TBL] [Abstract][Full Text] [Related]
12. The burden of psychotropic and anticholinergic medicines use in care homes: population-based analysis in 147 care homes.
Grill P; Marwick C; De Souza N; Burton JK; Hughes C; Guthrie B
Age Ageing; 2021 Jan; 50(1):183-189. PubMed ID: 32706851
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Nine Instruments to Calculate Anticholinergic Load in a Large Cohort of Older Outpatients: Association with Cognitive and Functional Decline, Falls, and Use of Laxatives.
Mayer T; Meid AD; Saum KU; Brenner H; Schöttker B; Seidling HM; Haefeli WE
Am J Geriatr Psychiatry; 2017 May; 25(5):531-540. PubMed ID: 28233606
[TBL] [Abstract][Full Text] [Related]
14. Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data.
Niznik J; Zhao X; Jiang T; Hanlon JT; Aspinall SL; Thorpe J; Thorpe C
Drugs Aging; 2017 Dec; 34(12):925-939. PubMed ID: 29214512
[TBL] [Abstract][Full Text] [Related]
15. Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study.
Pasina L; Colzani L; Cortesi L; Tettamanti M; Zambon A; Nobili A; Mazzone A; Mazzola P; Annoni G; Bellelli G
Drugs Aging; 2019 Jan; 36(1):85-91. PubMed ID: 30484239
[TBL] [Abstract][Full Text] [Related]
16. Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study.
Pasina L; Lucca U; Tettamanti M
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1696-1702. PubMed ID: 33098318
[TBL] [Abstract][Full Text] [Related]
17. Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales.
Novella A; Elli C; Ianes A; Pasina L
Drugs Aging; 2023 Nov; 40(11):1017-1026. PubMed ID: 37620654
[TBL] [Abstract][Full Text] [Related]
18. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes.
Hsu WH; Wen YW; Chen LK; Hsiao FY
Ann Fam Med; 2017 Nov; 15(6):561-569. PubMed ID: 29133497
[TBL] [Abstract][Full Text] [Related]
19. Anticholinergic burden in older adults with psychiatric illnesses: A cross-sectional study.
Chahine B; Al Souheil F; Yaghi G
Arch Psychiatr Nurs; 2023 Jun; 44():26-34. PubMed ID: 37197858
[TBL] [Abstract][Full Text] [Related]
20. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
